v3.25.2
Condensed Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities:    
Net income (loss) $ 2,546,625 $ (605,905)
Equity in loss of equity method investees 108,163
Accretion of discount on note payable 60,417 88,531
Gain on derivative instrument (25,000)
Gain on disposal of equity method investment (1,171,760)
Relief of indebtedness income (1,697,024)
Accrued interest added to notes payable and convertible debt 102,451 97,034
Stock-based compensation 8,838 22,331
Change in operating assets and liabilities:    
Accounts receivable, administrative fees 10,500 (4,500)
Prepaid expenses 1,086 17,151
Accounts payable 28,374 55,773
Accrued expenses 76,230
Net cash used in operating activities (110,493) (170,192)
Cash flows from investing activities:    
Loans made (250,000)
Net cash used in investing activities (250,000)
Cash flows from financing activities:    
Proceeds from issuances of short term notes payable 105,500 100,000
Proceeds from issuance of long term notes payable 275,000
Net cash provided by financing activities 105,500 375,000
Net change in cash (4,993) (45,192)
Cash at the beginning of the period 6,099 53,063
Cash at the end of the period 1,106 7,871
Cash paid during the period for:    
Interest 1,094 883
Supplemental Non-Cash Investing and Financing Activities:    
Interest capitalized to notes payable 36,000 97,034
Settlement of long term notes payable 2,997,025
Settlement of derivative liability, net of interest $ 614,000